Difficulty: Medium
Average Score: 73%
Simulated
A client with chronic kidney disease (CKD) is receiving calcium acetate 667 mg PO. A decrease in which blood value indicates to the nurse that the medication is having the desired effect?
Correct answer
C
Rationale
The correct answer is C: Phosphate. Calcium acetate is a phosphate binder used in CKD to lower elevated phosphate levels. By binding with dietary phosphate in the GI tract, it decreases phosphate absorption, leading to lower serum phosphate levels. Monitoring phosphate levels is crucial in CKD to prevent complications like vascular calcification. The other choices are incorrect because: A) Potassium is not directly affected by calcium acetate, B) Calcium levels may fluctuate but are not the primary target of this medication, D) pH is not directly impacted by calcium acetate in the context of CKD.